Dr Paul Griffin

Affiliate Senior Lecturer

Mater Research Institute-UQ
Faculty of Medicine

Conjoint Senior Lecturer

Mater Clinical Unit
Faculty of Medicine

Overview

An Infectious Diseases Physician and Microbiologist, Dr Paul Griffin was appointed as the Director of Infectious Diseases at Mater Health Services in 2013. In addition Dr Griffin continues appointments as Principal Investigator at Q-Pharm, as Visiting Scientist/Honorary Research Fellow at Mater Medical Research Institute and Queensland Institute of Medical Research, and also as Senior Lecturer at the University of Queensland.

Dr Paul Griffin's primary research interests include clinical trials in the field of infectious diseases particularly malaria human challenge and transmission blocking studies, as well as the detection of antibiotic resistance particularly VRE by mass spectrometry in the clinical microbiology laboratory.

Qualifications

  • Bachelor of Medicine & Bachelor of Surgery
  • Bachelor of Science (Honours)

Publications

View all Publications

Publications

Book Chapter

  • Griffin, Paul (2014). Australian Bat Lyssavirus. In Victor L. Yu, Rainer Weber and Didier Raoult (Ed.), Infectious Disease and Antimicrobial Agents (pp. 1-1) Pittsburgh, PA, USA: Antimicrobe.

  • Griffin, Paul (2014). Barmah Forest Virus. In Victor L. Yu, Rainer Weber and Didier Raoult (Ed.), Infectious Disease and Antimicrobial Agents (pp. 1-1) Pittsburgh, PA, USA: Antimicrobe.

  • Griffin, P. M. (2014). Menangle. In Infectious Disease and Antimicrobial Agents (pp. 1-1) Pittsburgh, PA, United States: Antimicrobe.

  • Griffin, Paul (2014). Ross River Virus. In Infectious Disease and Antimicrobial Agents (pp. 1-1) Pittsburgh, PA, United States: Antimicrobe.

  • Griffin, Paul M. (2010). Diloxanide furoate. In M. Lindsay Grayson, Suzanne M. Crowe, James S. McCarthy, John Mills, Johan W. Mouton, S. Ragnar Norrby, David L. Paterson and Michael A. Pfaller (Ed.), Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic and Antiviral Drugs 6th ed. (pp. 2121-2124) Boca Raton, FL, USA: CRC Press. doi:10.1201/b13787-206

  • Griffin, Paul M. (2010). Furazolidone (furazolidine). In M. Lindsay Grayson, Suzanne M. Crowe, James S. McCarthy, John Mills, Johan W. Mouton, S. Ragnar Norrby, David L. Paterson and Michael A. Pfaller (Ed.), Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic and Antiviral Drugs 6th ed. (pp. 2114-2120) Boca Raton, FL, USA: CRC Press. doi:10.1201/b13787-205

  • Griffin, Paul M. and McCarthy, James (2010). Niclosamide. In M. Lindsay Grayson, Suzanne M. Crowe, James S. McCarthy, John Mills, Johan W. Mouton, S. Ragnar Norrby, David L. Paterson and Michael A. Pfaller (Ed.), Kucers' the use of antibiotics: a clinical review of antibacterial, antifungal, antiparasitic and antiviral drugs 6th edition ed. (pp. 2293-2296) Boca Raton, FL, United States: CRC Press. doi:10.1201/b13787-232

Journal Article

Conference Publication

  • Spelman, L., Johnston, J., Prow, T., Yamada, M., Griffin, P., Wood, D. and Miller, D. (2016). First-in-human phase 1 safety study of BLZ-100 in subjects with skin cancer. In: Australasian College of Dermatologists 49th Annual Scientific Meeting, Perth, Australia, (25-25). 14–17 May 2016.

  • Stein, Daniel, Jain, Jay Prakash, Lickliter, Jason, Kangas, Michael, Machineri, Surendra and Griffin, Paul (2014). A phase 1 evaluation of the pharmacokinetic/pharmacodynamics interaction of the antimalarial agent KAE609 and piperaquine (PPQ). In: Malaria Journal. Challanges in malaria research: Core science and innovation, Oxford, United Kingdom, (P85-P85). 22-24 September 2014. doi:10.1186/1475-2875-13-S1-P85

  • Griffin, Paul, Price, Gareth, Hamilton, Brett, Schooneveldt, Jacqueline, Urbanski, Tess, Schlebusch, Sanmarie and Venter, Deon (2013). Rapid Identification of Vancomycin Resistant Enterococci with Maldi-Tof Mass Spectrometry. In: Abstracts for the RACP Future Directions in Health Congress 2013. The Royal Australasian College of Physicians Future Directions in Health Congress 2013 (RACP), Perth WA, Australia, (27-27). 26-29 May 2013. doi:10.1111/imj.12153